Medication Burden Reduction Through Geriatric Pharmacy Practice

Abstract

Polypharmacy among older adults is a significant public health concern, contributing to increased morbidity, adverse drug events, hospitalizations, and diminished quality of life. Geriatric pharmacy practice—through medication review, deprescribing initiatives, and interdisciplinary collaboration—emerges as a crucial strategy for reducing medication burden. This review synthesizes recent evidence, elucidates mechanisms underlying medication burden, and discusses guideline-based interventions, with an emphasis on practical implications for clinicians managing complex geriatric patients.

Introduction

Medication burden, defined as the cumulative impact of multiple drug therapies, is pervasive in geriatric populations. With advancing age, physiological changes and multimorbidity often necessitate complex pharmacotherapy, increasing the risk of adverse drug reactions (ADRs) and drug-drug interactions. Geriatric pharmacy practice, a specialized field focused on optimizing pharmacotherapy in older adults, has gained prominence as evidence reveals that systematic medication management can significantly reduce medication-related harm. This article provides a comprehensive overview of the clinical impact of medication burden, the role of geriatric pharmacy, and practical approaches for reduction, integrating recent research and guideline recommendations.

Epidemiology / Disease Burden

Polypharmacy, commonly defined as the regular use of five or more medications, affects up to 40% of individuals aged ≥65 years globally. Studies indicate that inappropriate medication use, including potentially inappropriate medications (PIMs), is prevalent in this population, with estimates ranging from 20% to 60% depending on the setting. Data from large cohort studies, such as the National Health and Aging Trends Study (NHATS), highlight a direct correlation between polypharmacy and increased hospitalizations, cognitive decline, falls, and mortality. The economic burden is substantial, with medication-related problems contributing to billions in health care costs annually, emphasizing the urgency for effective interventions.

Pathophysiology

Age-related physiological changes in pharmacokinetics and pharmacodynamics—such as decreased renal and hepatic clearance, altered body composition, and receptor sensitivity—heighten susceptibility to drug toxicity and interactions in older adults. The pathophysiology of medication burden is further complicated by the presence of multiple chronic diseases, leading to prescribing cascades, where drugs are prescribed to manage side effects of other medications, perpetuating a cycle of polypharmacy. Polypharmacy can contribute to frailty, impaired cognition, and functional decline, underscoring the need for individualized pharmacotherapy in the elderly.

Risk Factors

Key risk factors for increased medication burden include advanced age, multimorbidity, multiple prescribers, fragmented care, recent hospitalization, and lack of regular medication review. Sociodemographic factors such as low health literacy, limited access to healthcare, and social isolation further exacerbate risk. Specific conditions—such as heart failure, diabetes, and dementia—are commonly associated with higher medication counts. The presence of cognitive impairment and frailty increases vulnerability to adverse outcomes from polypharmacy, reinforcing the necessity for ongoing risk assessment and tailored interventions.

Clinical Features

Clinical manifestations of medication burden may be subtle and nonspecific, often presenting as falls, delirium, cognitive impairment, urinary incontinence, and functional decline. Adverse drug events (ADEs) and drug-drug interactions are common, with geriatric syndromes frequently linked to inappropriate medication use. Polypharmacy also contributes to medication nonadherence, increasing the likelihood of therapeutic failure and hospital readmissions. Detecting these features requires high clinical vigilance, comprehensive history-taking, and targeted screening tools.

Diagnosis

The diagnosis of clinically significant medication burden involves systematic medication review, often employing validated tools such as the Beers Criteria, STOPP/START criteria, and Medication Appropriateness Index (MAI). Comprehensive geriatric assessment (CGA) provides a multidimensional approach to evaluate medical, cognitive, functional, and psychosocial factors influencing medication use. Medication reconciliation at each transition of care, coupled with assessment of adherence and adverse effects, forms the cornerstone of effective diagnosis and identification of polypharmacy-related problems.

Treatment & Management

Management strategies center on deprescribing—systematic withdrawal of inappropriate medications—while ensuring therapeutic efficacy and patient safety. Geriatric pharmacists play a pivotal role through medication therapy management (MTM), identifying PIMs, optimizing dosing, and facilitating shared decision-making with patients and caregivers. Interdisciplinary collaboration among physicians, nurses, and pharmacists enhances the detection and resolution of medication-related issues. Patient education, regular follow-up, and use of electronic health records (EHRs) to flag high-risk regimens are essential for sustaining medication burden reduction.

Recent Advances / Emerging Therapies

Recent advances in geriatric pharmacy include the integration of artificial intelligence (AI)-driven clinical decision support systems (CDSS) for medication optimization, and the development of deprescribing guidelines tailored to specific conditions such as dementia and chronic pain. Randomized controlled trials (RCTs) have demonstrated that pharmacist-led interventions significantly reduce PIMs and improve clinical outcomes. Innovations in telepharmacy and remote monitoring are expanding access to geriatric pharmacy services, particularly in underserved and rural populations.

Guideline Recommendations

Major guidelines, including those from the American Geriatrics Society (AGS), advocate for regular medication review, avoidance of PIMs per Beers Criteria, and the application of deprescribing algorithms. The World Health Organization (WHO) emphasizes the importance of integrated, person-centered care, recommending multidisciplinary approaches for medication management in older adults. National and international consensus statements highlight the need for ongoing education of healthcare professionals in geriatric pharmacotherapy and encourage routine implementation of structured medication review protocols.

Conclusion

Medication burden reduction is a critical component of geriatric care, with substantial clinical and economic benefits. Geriatric pharmacy practice, through comprehensive medication management and deprescribing initiatives, offers an evidence-based approach to optimize pharmacotherapy, reduce harm, and improve outcomes in older adults. Ongoing research, advances in technology, and adherence to guideline recommendations will be essential to further enhance the role of geriatric pharmacy in addressing the challenges of polypharmacy and medication burden in aging populations.